FDA Warns California OTC Drugmaker for CGMP Violations

Drug Industry Daily
A A
The FDA issued a warning letter to Samson Pharmaceuticals, a Commerce, California OTC drug manufacturer, for serious CGMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily